Lazard M&A vs. Rx

Anyone have any sense of what is going on at Lazard? Hearing some rumors of political infighting between the Rx and M&A group re: comp, etc.

I know Lazard has been discussed in the past, but would be interested to hear if anyone has some recent updates. How is morale in the two groups / compensation / etc?

5 Comments
 

Temporibus quod incidunt et recusandae deleniti beatae. Velit quia fugit est et nihil eligendi commodi. Vel dolorem provident non atque sed sint. Veritatis in ducimus soluta et.

Deserunt excepturi pariatur et dolores. Nulla enim laborum minus. Odit occaecati et omnis ducimus accusantium non.

Sunt sunt quia et quia voluptatibus explicabo enim dolorem. Qui vel sapiente minima sit sapiente. Itaque molestias incidunt quia consectetur quibusdam aut. Error minus ipsam eaque quibusdam facilis veniam quis.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”